Galena Biopharma Inc (GALE)

0.35
0.00 1.00
NASDAQ : Health Care
Prev Close 0.35
Open 0.35
Day Low/High 0.35 / 0.35
52 Wk Low/High 0.28 / 2.49
Volume 41.93K
Avg Volume 564.30K
Exchange NASDAQ
Shares Outstanding 38.60M
Market Cap 13.51M
EPS -2.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1

An SEC enforcement action uncovers the deep involvement and brazen misbehavior of biotech CEOs in an illegal stock promotion scheme.

Deadline Alert: GPM Reminds Investors Of The April 14 Deadline In The Class Action Lawsuit Against Galena Biopharma, Inc.

Glancy Prongay & Murray LLP ("GPM") reminds investors of the April 14, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Galena Biopharma, Inc.

DEADLINE ALERT: Brower Piven Reminds Investors Of The Upcoming Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess Of $100,000 From Investment In Galena Biopharma, Inc. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Galena Biopharma, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

How to Dig Deep for Value in These Exuberant Markets

How to Dig Deep for Value in These Exuberant Markets

Look for beaten-down stocks that are trading at discounts to the value of their assets. Finding absolute bottoms in stocks is not as important as you may think.

Value Investors Have to Go Deeper

Value Investors Have to Go Deeper

Look for beaten-down stocks that are trading at discounts to the value of their assets.

GALE FRAUD NOTICE: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors Of Important Deadline In Class Action - GALE

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Galena Biopharma, Inc.

Glancy Prongay & Murray LLP Files Securities Class Action Lawsuit Against Galena BioPharma, Inc.

Glancy Prongay & Murray LLP ("GPM") announces that it has filed a class action lawsuit in the United States District Court for the District of New Jersey on behalf of a class (the "Class") consisting of persons...

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Galena Biopharma, Inc.

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of Galena Biopharma, Inc.

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Galena Biopharma Inc. And Encourages Investors To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Galena Biopharma Inc.

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Galena Biopharma Inc. And Encourages Investors To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Galena Biopharma Inc.

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Galena Biopharma, Inc. - GALE

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Galena Biopharma, Inc.

Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments

Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments

Cramer points to Gilead's pipeline for its problems.